Stockreport

Neurocrine succeeds in mid-stage trial for Takeda-partnered depression drug [Seeking Alpha]

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)  (TAK) 
PDF with Takeda Pharmaceutical ( NYSE: TAK ), reached its main goals in adults with major depressive disorder. SAVITRI, designed to test two dose levels of NBI-1065845 (TA [Read more]